159 related articles for article (PubMed ID: 38389944)
1. Comparative analysis of antibiotic susceptibility patterns and clinical features of mucoid and non-mucoid
Luo M; Li S; Luo W
Front Public Health; 2024; 12():1333477. PubMed ID: 38389944
[TBL] [Abstract][Full Text] [Related]
2. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study.
Cho CH; Lee SB
BMC Ophthalmol; 2018 Aug; 18(1):204. PubMed ID: 30126384
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and antimicrobial susceptibility of Pseudomonas aeruginosa mucoid and non-mucoid type.
Srifuengfung S; Tiensasitorn C; Yungyuen T; Dhiraputra C
Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):893-6. PubMed ID: 15916087
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.
Millar BC; McCaughan J; Rendall JC; Downey DG; Moore JE
J Clin Pharm Ther; 2018 Feb; 43(1):92-100. PubMed ID: 29293275
[TBL] [Abstract][Full Text] [Related]
6. [A control study on bacterial resistance and clinical features of lower respiratory tract infection with Pseudomonas aeruginosa in medical intensive care unit and general ward].
Shao C; Qu J; He L; Ni C; Hu B
Zhonghua Nei Ke Za Zhi; 2002 Dec; 41(12):813-7. PubMed ID: 12654234
[TBL] [Abstract][Full Text] [Related]
7. The impact of multi-drug resistant Pseudomonas aeruginosa infections on acute pancreatitis patients.
Wu D; Lu W; Huang Y; Qin G; Liu H; Xiao J; Peng J
BMC Infect Dis; 2023 May; 23(1):340. PubMed ID: 37217844
[TBL] [Abstract][Full Text] [Related]
8. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
Millar BC; Rendall JC; Downey DG; Moore JE
J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the biological characteristics of mucoid and non-mucoid Pseudomonas aeruginosa strains isolated from chronic respiratory infections.
Meitert E; Sima F; Savulian C; Chersulick E; Sălăgeanu A
Arch Roum Pathol Exp Microbiol; 1989; 48(3):193-207. PubMed ID: 2519631
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.
Mekonnen H; Seid A; Molla Fenta G; Gebrecherkos T
PLoS One; 2021; 16(11):e0257272. PubMed ID: 34780494
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.
Ogbolu DO; Ogunledun A; Adebiyi OE; Daini OA; Alli AO
Afr J Med Med Sci; 2008 Dec; 37(4):339-44. PubMed ID: 19301711
[TBL] [Abstract][Full Text] [Related]
12. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
Manno G; Cruciani M; Romano L; Scapolan S; Mentasti M; Lorini R; Minicucci L
Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
[TBL] [Abstract][Full Text] [Related]
14. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006961. PubMed ID: 28628280
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Pseudomonas Aeruginosa and its Antibiotic Sensitivity Pattern.
Pokharel K; Dawadi BR; Bhatt CP; Gupte S
J Nepal Health Res Counc; 2019 Apr; 17(1):109-113. PubMed ID: 31110388
[TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial resistance in clinical patterns of Pseudomonas aeruginosa].
del Mar Casal M; Causse M; Rodríguez-López F; Casal M
Rev Esp Quimioter; 2012 Mar; 25(1):37-41. PubMed ID: 22488540
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
[TBL] [Abstract][Full Text] [Related]
18. [Changes of drug-resistance of Pseudomonas aeruginosa in pediatric intensive care unit].
Wang LJ; Sun Y; Song WL; Zhang ZJ; Liu CF
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):657-63. PubMed ID: 23158814
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic resistance evolution of Pseudomonas aeruginosa in cystic fibrosis patients (2010-2013).
Lucca F; Guarnieri M; Ros M; Muffato G; Rigoli R; Da Dalt L
Clin Respir J; 2018 Jul; 12(7):2189-2196. PubMed ID: 29498795
[TBL] [Abstract][Full Text] [Related]
20. Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002.
Mohr JF; Jones A; Ostrosky-Zeichner L; Wanger A; Tillotson G
Int J Antimicrob Agents; 2004 Oct; 24(4):346-51. PubMed ID: 15380259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
